Pisa, Italy

Ferrucio Bonino

This inventor holds 2 USPTO granted patents. Top assignee: University of Alberta. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ferrucio Bonino. Retrieved from https://idiyas.com/inventor/ferrucio-bonino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ferrucio Bonino: Innovator in Autoimmune Liver Disease

Introduction

Ferrucio Bonino is a notable inventor based in Pisa, Italy. He has made significant contributions to the field of autoimmune liver disease through his innovative research and patent.

Latest Patents

Ferrucio Bonino holds a patent related to biomarkers in autoimmune liver disease. This patent provides methods and compositions that are useful in identifying the presence of advanced stage autoimmune liver disease (ALD) in subjects diagnosed with the condition. Additionally, it includes methods for monitoring the effectiveness of treatment for ALD patients and identifying subjects who may be experiencing a relapse. The methods and compositions outlined in this patent also facilitate treatment decisions for individuals suffering from ALD.

Career Highlights

Ferrucio Bonino is affiliated with the University of Alberta, where he continues to advance research in his field. His work has garnered attention for its potential impact on the diagnosis and treatment of autoimmune liver diseases.

Collaborations

Some of his notable coworkers include Abdolamir Landi and Michael Houghton, who have collaborated with him on various research initiatives.

Conclusion

Ferrucio Bonino's contributions to the understanding and treatment of autoimmune liver disease highlight his role as an important innovator in the medical field. His patent on biomarkers represents a significant advancement in the management of this complex condition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…